Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesDividends payablesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Cash & Equivalents: 2016-2025

Historic Cash & Equivalents for cbdMD (YCBD) over the last 9 years, with Sep 2025 value amounting to $2.3 million.

  • cbdMD's Cash & Equivalents fell 7.80% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year decrease of 7.80%. This contributed to the annual value of $2.3 million for FY2025, which is 7.80% down from last year.
  • Per cbdMD's latest filing, its Cash & Equivalents stood at $2.3 million for Q3 2025, which was up 113.41% from $1.1 million recorded in Q2 2025.
  • In the past 5 years, cbdMD's Cash & Equivalents registered a high of $26.4 million during Q3 2021, and its lowest value of $1.1 million during Q2 2025.
  • In the last 3 years, cbdMD's Cash & Equivalents had a median value of $2.0 million in 2024 and averaged $2.0 million.
  • As far as peak fluctuations go, cbdMD's Cash & Equivalents soared by 78.16% in 2021, and later plummeted by 87.11% in 2023.
  • Quarterly analysis of 5 years shows cbdMD's Cash & Equivalents stood at $19.7 million in 2021, then tumbled by 82.98% to $3.4 million in 2022, then plummeted by 55.11% to $1.5 million in 2023, then skyrocketed by 30.92% to $2.0 million in 2024, then declined by 7.80% to $2.3 million in 2025.
  • Its Cash & Equivalents was $2.3 million in Q3 2025, compared to $1.1 million in Q2 2025 and $1.8 million in Q1 2025.